D47.01
Cutaneous mastocytosis
Clinical Classification Guidelines
Inclusion Terms
- Diffuse cutaneous mastocytosis
- Maculopapular cutaneous mastocytosis
- Solitary mastocytoma
- Telangiectasia macularis eruptiva perstans
- Urticaria pigmentosa
Excludes Type 1
- congenital (diffuse) (maculopapular) cutaneous mastocytosis (Q82.2)
- congenital urticaria pigmentosa (Q82.2)
- extracutaneous mastocytoma (D47.09)
Medical Intelligence & Overview
Cutaneous mastocytosis is a rare skin condition characterized by an abnormal accumulation of mast cells—immune-related cells—in the skin. This disorder can present in various forms, leading to skin changes that range from small spots to widespread dermatitis. It is most often diagnosed in children but can also affect adults. The condition may sometimes be associated with systemic symptoms or progression, but many cases are limited to the skin.
Causes & Symptoms
Clinical Causes: Genetic factors leading to abnormal mast cell growth Unknown exact causes, but mastocytosis involves proliferation of mast cells in the skin Possible triggers include infections, physical stimuli, or certain medications in some cases
Key Symptoms: Skin lesions such as brown or reddish skin spots or bumps Persistent itching or itching episodes triggered by hot showers, friction, or stress Red or flare-up reactions on the skin when touched or exposed to temperature changes Swelling or redness around the affected areas Formation of urticaria (hives) or flushing episodes Possible development of telangiectasia macularis eruptiva perstans, presenting as flat, enlarged blood vessels
Diagnostic & Treatment
Diagnosis Path: Diagnosis involves a detailed medical history, physical examination of skin lesions, and skin biopsies to identify increased mast cell presence. Additional tests may include blood tests to assess mast cell activity and rule out systemic involvement. The pattern of skin lesions and their response to triggers can also aid diagnosis.
Treatment Protocols: While there's no cure for cutaneous mastocytosis, various treatments can help manage symptoms. Options include antihistamines to reduce itching and allergic reactions, topical corticosteroids to soothe inflamed skin, and medications to prevent mast cell degranulation. Avoiding known triggers and skin irritants is recommended. In some cases, phototherapy or other specialized treatments may be considered. Regular monitoring by healthcare professionals is essential to manage and address any progression or complications.
Clinical Advice & FAQs
Billing Guidance
Is D47.01 a billable ICD-10 code?
Yes, D47.01 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report D47.01?
Clinical documentation must specify the nature of Cutaneous mastocytosis and any associated comorbidities for accurate reporting.
Cite this Clinical Reference
